Cal-Maine Founders Sold $320M in Stock Weeks After Price-Fixing Probe Began
The timing of the Adams family's equity sale relative to the federal investigation creates a public record trail that prosecutors, regulators, and shareholders may scrutinize for months to come.
The Adams family, founders and controlling shareholders of Cal-Maine Foods — the largest egg producer in the United States by volume — received approximately $320 million from the partial sale of their controlling stake in the Mississippi-based company, according to a report published by the New York Post on July 8, 2026, citing undisclosed sources familiar with the transaction. The sale occurred within weeks of federal investigators opening a probe into alleged egg price manipulation, according to the same report.
Cal-Maine Foods is publicly traded on the Nasdaq under the ticker CALM. The Adams family has held controlling interest in the company for approximately 70 years, according to the New York Post report. The family's equity liquidation occurred as Cal-Maine shares were trading near their all-time high, following a period in which the stock roughly doubled between mid-2022 and early 2025, a price trajectory that corresponded with a sustained rise in retail egg prices across U.S. grocery markets during the same period.
Federal scrutiny of egg pricing practices is not new. The U.S. Department of Justice Antitrust Division has previously investigated the egg industry; a 2008 civil class-action case, In re: Processed Egg Products Antitrust Litigation (E.D. Pa., MDL No. 2002), resulted in settlements totaling hundreds of millions of dollars from multiple producers. Whether the current probe represents a new investigation or an expansion of existing enforcement activity has not been confirmed in public court filings reviewed by The Congressional Times as of July 8, 2026.
Insider stock sales by corporate officers and major shareholders are legal when conducted in compliance with Securities and Exchange Commission rules, including pre-scheduled 10b5-1 trading plans, which are designed to insulate executives from accusations of trading on material non-public information. Whether the Adams family's $320 million sale was executed under a 10b5-1 plan is not confirmed in publicly available SEC filings reviewed by this publication. That information would be disclosed in Form 4 filings or Schedule 13D/G amendments on the SEC's EDGAR database.
Cal-Maine Foods had not issued a public statement responding to the New York Post report as of publication time. The U.S. Department of Justice did not confirm or deny the existence of an active investigation. What remains unknown: the precise date the federal probe commenced, the specific legal theory under investigation, whether any grand jury subpoenas have been issued, and whether the Adams family's share sale was governed by a pre-scheduled trading plan. SEC EDGAR filings for Cal-Maine Foods (CIK available through EDGAR full-text search) and any DOJ Antitrust Division public announcements would be the authoritative sources to resolve these questions.